Suchergebnisse
Trade Desk Q2 Earnings Call Highlights
Key Points
- Interested in The Trade Desk? Here are five stocks we like better.
- Q2 revenue rose 3% year over year to $715 million, but fell below expectations as large consumer packaged goods
Trevi Therapeutics Q2 Earnings Call Highlights
Key Points
- Interested in Trevi Therapeutics, Inc.? Here are five stocks we like better.
- Trevi launched two trials for nalbuphine ER (Haduvio) in chronic cough during Q2: the Phase III OCEAN-1
TripAdvisor Q2 Earnings Call Highlights
Key Points
- Interested in TripAdvisor, Inc.? Here are five stocks we like better.
- TripAdvisor plans to sell TheFork to American Express for $700 million, expecting approximately $680 million in
Oncology Institute Q2 Earnings Call Highlights
Key Points
- Interested in The Oncology Institute, Inc.? Here are five stocks we like better.
- Second-quarter performance improved significantly: Revenue rose 34.6% year over year to $161.3
Treace Medical Concepts Q2 Earnings Call Highlights
Key Points
- Interested in Treace Medical Concepts, Inc.? Here are five stocks we like better.
- Q2 revenue fell 4% to $45.4 million, pressured by lower stocking-distributor kit sales and a shift
Here's What Key Metrics Tell Us About Sweetgreen (SG) Q2 Earnings
For the quarter ended June 2026, Sweetgreen, Inc. (SG) reported revenue of $192.66 million, up 3.8% over the same period last year. EPS came in at -$0.22, compared to -$0.20 in the year-ago quarter.
eBay (EBAY) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
For the quarter ended June 2026, eBay (EBAY) reported revenue of $3.13 billion, up 14.8% over the same period last year. EPS came in at $1.60, compared to $1.37 in the year-ago quarter.
The reported
Helmerich & Payne (HP) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
For the quarter ended June 2026, Helmerich & Payne (HP) reported revenue of $1.03 billion, down 0.6% over the same period last year. EPS came in at -$0.11, compared to $0.22 in the year-ago quarter.
SOUN Raises 2026 Revenue Outlook After OASYS Drives Record Q2 Sales
SoundHound AI, Inc. SOUN delivered a record second quarter as enterprise demand for OASYS helped lift revenues and management raised the floor of its 2026 outlook. The result strengthens the case
Is SOUN Worth Buying as Growth Collides With a Premium Valuation?
SoundHound AI, Inc. SOUN offers a high-growth enterprise AI story, but the stock still asks investors to accept a premium sales multiple, ongoing losses and substantial execution risk.The case for
SOUN Dips 16.9% in 3 Months. Can Stronger Growth Reverse the Slide?
SoundHound AI, Inc. SOUN shares have lost 16.9% in the past three months even as second-quarter revenues, enterprise adoption and operating metrics improved. That split between price action and
Can MED's Trilivy Launch and Cost Cuts Drive a Q4 Profit Turnaround?
Medifast, Inc. MED is entering a decisive phase of its turnaround as the Trilivy metabolic-health platform rolls out alongside another round of cost reductions. Management expects progress toward
Sunrun (RUN) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
For the quarter ended June 2026, Sunrun (RUN) reported revenue of $869.99 million, up 52.8% over the same period last year. EPS came in at $0.42, compared to $1.07 in the year-ago quarter.
The
Compared to Estimates, Matador (MTDR) Q2 Earnings: A Look at Key Metrics
For the quarter ended June 2026, Matador Resources (MTDR) reported revenue of $1.19 billion, up 32.5% over the same period last year. EPS came in at $2.61, compared to $1.53 in the year-ago quarter.
Versant Q2 Earnings Call Highlights
Key Points
- Interested in Versant Corporation? Here are five stocks we like better.
- Q2 revenue fell 4% to $1.64 billion, pressured by a 6% decline in linear distribution revenue, while adjusted
VSE Q2 Earnings Call Highlights
Key Points
- Interested in VSE Corporation? Here are five stocks we like better.
- Record Q2 performance: Revenue rose 65% year over year to $449 million, while adjusted EBITDA nearly doubled to
Verrica Pharmaceuticals Q2 Earnings Call Highlights
Key Points
- Interested in Verrica Pharmaceuticals Inc.? Here are five stocks we like better.
- YCANTH sales accelerated: U.S. net product revenue rose 18.7% sequentially to $5.1 million, while
Vital Farms Q2 Earnings Call Highlights
Key Points
- Interested in Vital Farms, Inc.? Here are five stocks we like better.
- Q2 results weakened significantly: Net revenue fell 10.1% year over year to $166 million, while adjusted EBITDA
Ultralife Q2 Earnings Call Highlights
Key Points
- Interested in Ultralife Corporation? Here are five stocks we like better.
- Ultralife’s Q2 performance improved despite slightly lower revenue: Revenue was $47.9 million, down modestly


